| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Praveen Tripathi, Hemika Agrawal, Priyanka Goyal, Sujita Kumar Ka. Olanzapine-induced neuroleptic malignant syndrome in a patient with bipolar affective disorder: Does quetiapine holds the solution? Industrial psychiatry journal. vol 22. issue 2. 2014-07-11. PMID:25013321. |
in this case report- we highlight the management issues of a patient suffering from bipolar affective disorder, who had developed nms following intramuscular injection of haloperidol, which was withdrawn and olanzapine was given later on. |
2014-07-11 |
2023-08-13 |
Not clear |
| Praveen Tripathi, Hemika Agrawal, Priyanka Goyal, Sujita Kumar Ka. Olanzapine-induced neuroleptic malignant syndrome in a patient with bipolar affective disorder: Does quetiapine holds the solution? Industrial psychiatry journal. vol 22. issue 2. 2014-07-11. PMID:25013321. |
the patient had again developed nms with olanzapine. |
2014-07-11 |
2023-08-13 |
Not clear |
| Anna Szota, Ewa Ogłodek, Aleksander Araszkiewic. Fever development in neuroleptic malignant syndrome during treatment with olanzapine and clozapine. Pharmacological reports : PR. vol 65. issue 2. 2014-02-07. PMID:23744413. |
the aim of this article is to describe how olanzapine and clozapine influence fever development in nms, in relation to the dose of the drug taken by schizophrenic patients including changes in immunological system. |
2014-02-07 |
2023-08-12 |
Not clear |
| Young Kyoung Sa, Hyeon Yang, Hee Kyoung Jung, Jang Won Son, Seong Su Lee, Seong Rae Kim, Bong Yeon Cha, Ho Young Son, Chi-Un Pae, Soon Jib Yo. Olanzapine-induced diabetic ketoacidosis and neuroleptic malignant syndrome with rhabdomyolysis: a case report. Endocrinology and metabolism (Seoul, Korea). vol 28. issue 1. 2014-01-07. PMID:24396655. |
here, we report a patient who simultaneously developed dka, acute renal failure and nms with rhabdomyolysis after olanzapine treatment. |
2014-01-07 |
2023-08-12 |
Not clear |
| Young Kyoung Sa, Hyeon Yang, Hee Kyoung Jung, Jang Won Son, Seong Su Lee, Seong Rae Kim, Bong Yeon Cha, Ho Young Son, Chi-Un Pae, Soon Jib Yo. Olanzapine-induced diabetic ketoacidosis and neuroleptic malignant syndrome with rhabdomyolysis: a case report. Endocrinology and metabolism (Seoul, Korea). vol 28. issue 1. 2014-01-07. PMID:24396655. |
olanzapine-induced metabolic complications and nms were dramatically improved with cessation of the olanzapine treatment and initiation of supportive management including fluid therapy, hemodialysis, and intensive glycemic control using insulin. |
2014-01-07 |
2023-08-12 |
Not clear |
| Bichitra Nanda Patra, Sudhir K Khandelwal, Mamta Soo. Olanzapine induced neuroleptic malignant syndrome. Indian journal of pharmacology. vol 45. issue 1. 2013-09-26. PMID:23543750. |
an 18 year old male diagnosed as a case of bipolar affective disorder (bpad), developed neuroleptic malignant syndrome (nms) following treatment with olanzapine (20 mg per day), an atypical antipsychotic drug. |
2013-09-26 |
2023-08-12 |
Not clear |
| Naseem A Quresh. Neuroleptic malignant syndrome. Diagnostic and therapeutic dilemmas in a general hospital setting. Neurosciences (Riyadh, Saudi Arabia). vol 13. issue 4. 2012-10-02. PMID:21063378. |
after 3 days, she suddenly developed signs and symptoms of nms possibly caused by prn injectable haloperidol, although the additional role of olanzapine could not be ruled out. |
2012-10-02 |
2023-08-12 |
Not clear |
| Megan E Musselman, Linda A Browning, Dennis Parker, Suprat Sael. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome. The Annals of pharmacotherapy. vol 45. issue 11. 2012-04-16. PMID:21972252. |
to describe a case of neuroleptic malignant syndrome (nms) associated with the use of prochlorperazine in a patient recently hospitalized for nms secondary to olanzapine. |
2012-04-16 |
2023-08-12 |
Not clear |
| Pang-Yen Liu, Pei-Chuan Wu, Chun-Yen Chen, Yi-Chyan Che. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome. General hospital psychiatry. vol 33. issue 1. 2011-07-25. PMID:21353143. |
nms subsided and psychotic features were controlled after both antipsychotics were discontinued and the patient was treated instead with olanzapine. |
2011-07-25 |
2023-08-12 |
Not clear |
| b' Mehmet Ust\\xc3\\xbcnda\\xc4\\x9f, Murat Orak, Cahfer G\\xc3\\xbclo\\xc4\\x9flu, Mustafa Burak Sayhan, Mahmut Ta\\xc5\\x9. A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period. Indian journal of psychiatry. vol 49. issue 4. 2011-07-14. PMID:20680143.' |
incidence of nms induced by olanzapine - an atypical antipsychotic - is extremely rare. |
2011-07-14 |
2023-08-12 |
Not clear |
| D N Mendhekar, R C Jiloha, M M Mehndiratta, L Wa. Challenge with atypical antipsychotic drugs in risperidone induced neuroleptic malignant syndrome: a case report. Indian journal of psychiatry. vol 44. issue 4. 2011-07-14. PMID:21206609. |
ultimately post nms psychosis responded well to olanzapine 10mg and there was no recurrence of nms. |
2011-07-14 |
2023-08-12 |
Not clear |
| D N Mendhekar, R C Jiloha, M M Mehndiratta, L Wa. Challenge with atypical antipsychotic drugs in risperidone induced neuroleptic malignant syndrome: a case report. Indian journal of psychiatry. vol 44. issue 4. 2011-07-14. PMID:21206609. |
olanzapine may be the better choice for the treatment of post nms psychosis. |
2011-07-14 |
2023-08-12 |
Not clear |
| Adeeb Yacoub, Andrew Franci. Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam. Neuropsychiatric disease and treatment. vol 2. issue 2. 2011-05-17. PMID:19412469. |
the authors report three cases of neuroleptic malignant syndrome (nms) induced by atypical antipsychotics (olanzapine and clozapine) which showed classic features of nms including muscular rigidity and prominent fever. |
2011-05-17 |
2023-08-12 |
Not clear |
| Julian N Trollor, Xiaohua Chen, Perminder S Sachde. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS drugs. vol 23. issue 6. 2009-08-18. PMID:19480467. |
we used medline and embase to identify nms case reports and systematic reviews published to june 2008 related to the atypical antipsychotic drugs clozapine, olanzapine, risperidone, paliperidone, aripiprazole, ziprasidone, amisulpride and quetiapine. |
2009-08-18 |
2023-08-12 |
Not clear |
| Ashish Srivastava, Hirabai A Borkar, Sumitkumar Chanda. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia. Psychiatry and clinical neurosciences. vol 63. issue 1. 2009-04-16. PMID:19067992. |
a case of a male patient with schizophrenic illness who developed neuroleptic malignant syndrome (nms) following treatment with olanzapine is reported. |
2009-04-16 |
2023-08-12 |
Not clear |
| Ashish Srivastava, Hirabai A Borkar, Sumitkumar Chanda. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia. Psychiatry and clinical neurosciences. vol 63. issue 1. 2009-04-16. PMID:19067992. |
case reports have been published concerning nms and clozapine,(1) risperidone(2) and olanzapine. |
2009-04-16 |
2023-08-12 |
Not clear |
| Paul E Croarkin, Graham J Emslie, Taryn L Maye. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. The Journal of clinical psychiatry. vol 69. issue 7. 2008-09-09. PMID:18572981. |
to retrospectively examine published cases of neuroleptic malignant syndrome (nms) in patients aged 18 and below who had been treated with atypical antipsychotics (clozapine, risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole). |
2008-09-09 |
2023-08-12 |
Not clear |
| Debra L Stevens, Matthew R Lee, Yolanda Padu. Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy. Pharmacotherapy. vol 28. issue 3. 2008-06-03. PMID:18294120. |
we describe a 58-year-old man with down syndrome and dementia who was receiving low-dose olanzapine and rivastigmine therapy; he developed nms 4 months after starting olanzapine. |
2008-06-03 |
2023-08-12 |
Not clear |
| Debra L Stevens, Matthew R Lee, Yolanda Padu. Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy. Pharmacotherapy. vol 28. issue 3. 2008-06-03. PMID:18294120. |
based on the naranjo adverse drug reaction probability scale, olanzapine was the probable cause of the patient's nms. |
2008-06-03 |
2023-08-12 |
Not clear |
| Debra L Stevens, Matthew R Lee, Yolanda Padu. Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy. Pharmacotherapy. vol 28. issue 3. 2008-06-03. PMID:18294120. |
in addition, use of rivastigmine in combination with olanzapine may have placed the patient at greater risk for nms, possibly due to an acetylcholine-dopamine imbalance. |
2008-06-03 |
2023-08-12 |
Not clear |